Download PDF
Thromb Haemost 1974; 31(02): 354-362
DOI: 10.1055/s-0038-1649170
Original Article
Schattauer GmbH

Platelet Aggregation Induced by DAS in Vitro: Some Investigations on Its Mechanism of Action[*]

K. U Benner
1   Institute of Normal and Pathological Physiology, University of Cologne, and Institute of Experimental Therapy, University of Freiburg, Germany
,
K. A Schumacher
1   Institute of Normal and Pathological Physiology, University of Cologne, and Institute of Experimental Therapy, University of Freiburg, Germany
,
H. G Classen
1   Institute of Normal and Pathological Physiology, University of Cologne, and Institute of Experimental Therapy, University of Freiburg, Germany
› Author Affiliations
Further Information

Publication History

Received 10 September 1973

Accepted 06 February 1974

Publication Date:
29 June 2018 (online)

    Permissions and Reprints

Summary

The effect of the depressor active substance (DAS) on platelets of men, cats, pigs, dogs, rats, and rabbits has been studied by the method of Born (1962). DAS was found to induce platelet aggregation only in human and feline platelet rich plasma (PRP). Nevertheless, there are some striking similarities between platelet aggregation induced by DAS and ADP (i.e. inhibition by the same compounds, such as adenosine, tosylarginine methylester, or p-chloromercuribenzoic acid). The species specifity and a marked tachyphylactic action on platelets of both species makes DAS clearly discernible from all the other aggregation inducing substances which have been studied so far. From additional experiments there is evidence that DAS acts on human and cat platelets via a release reaction of cellular substances known to enhance platelet aggregation in a second phase. This process is strongly dependent on the presence of Ca++.

* Partially presented at the IVth International Congress on Thrombosis and Haemo-stasis, Vienna 1973.


 

  • References

  • 1 Born G. V. R. Quantitative investigations into the aggregation of blood platelets. Journal of Physiology 1962; 162: 67
    PubMedGoogle Scholar
  • 2 Brecher G, Cronkite E. P. Morphology and enumeration of human blood platelets. Journal of Applied Physiology 1950; 3: 365
    CrossrefPubMedGoogle Scholar
  • 3 Cuthbertson W. F. J, Mills D. C. B. A miniature nephelometer for the study of platelet clumping. Journal of Physiology 1963; 168: 29
    CrossrefPubMedGoogle Scholar
  • 4 Macmillan D. C, Sim A. K. A comparative study of platelet aggregation in man and laboratory animals. Thrombosis et Diathesis Haemorrhagica 1970; 24: 385
    PubMedGoogle Scholar
  • 5 Marquardt P, und Hedler L. Standardisierung einer depressorisch aktiven Substanz aus Blut (Frühgift). Arzneimittel-Forschung 1958; 8: 423
    PubMedGoogle Scholar
  • 6 Rozenberg M. C, Holmsen H. Adenine nucleotide metabolism of blood platelets. IV Platelet aggregation response to exogenous ATP and ADP. Biochimica et Biophysica Acta 1968; 157: 280
    CrossrefPubMedGoogle Scholar
  • 7 Schumacher K. A, Classen H. G. Platelet aggregation and increased pulmonary vascular resistance in cats induced by DAS and ADP. Naunyn-Schmiede-berg’s Archiv für experimentelle Pathologie und Pharmakologie 1972; 275: 373
    PubMedGoogle Scholar
  • 8 Schumacher K. A, Classen H. G. The preventive effect of a low molecular pentosanpolysulfate (SP 54) on DAS-induced increase in pulmonary vascular resistance caused by platelet aggregation. Arzneimittel-Forschung 1973; 23: 431
    PubMedGoogle Scholar
  • 9 Schumacher K. A, Classen H. G, Marquardt P, Hedler L. The effect of DAS on respiration and pulmonary vascular resistance. Naunyn-Schmiedeberg’s Archiv für experimentelle Pathologie und Pharmakologie 1971; 271: 289
    PubMedGoogle Scholar